HomeSKYE • NASDAQ
add
Skye Bioscience Inc
Previous close
$0.71
Day range
$0.65 - $0.71
Year range
$0.61 - $5.75
Market cap
21.95M USD
Avg Volume
898.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Simply Wall Street
42 minutes ago
MKS Instruments SBTi Approval Adds ESG Dimension To Valuation Debate
0.019%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.90M | 39.65% |
Net income | -14.44M | -48.18% |
Net profit margin | — | — |
Earnings per share | -0.37 | -26.58% |
EBITDA | -14.72M | -40.27% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.74M | -62.38% |
Total assets | 28.31M | -61.09% |
Total liabilities | 8.29M | 79.73% |
Total equity | 20.02M | — |
Shares outstanding | 33.38M | — |
Price to book | 1.18 | — |
Return on assets | -106.95% | — |
Return on capital | -139.33% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -14.44M | -48.18% |
Cash from operations | -9.77M | -19.50% |
Cash from investing | -2.80M | -3,200.88% |
Cash from financing | 11.41K | 103.15% |
Net change in cash | -12.56M | -55.48% |
Free cash flow | -4.41M | -206.24% |
About
Founded
2011
Website
Employees
12
